Glenmark Pharmaceuticals Thursday said it will spin-off its innovation business into a separate company in the US, which will focus on therapeutic areas of immunology, oncology and pain management.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

It will house five clinical and three pre-clinical assets, and innovation-related research and development centres, manufacturing infrastructure and technology, an official statement said.

**********

Future Generali to recruit 215 people, 2376 new distributors

Future Generali India Life Insurance Company Thursday said it plans to recruit 215 people and appoint 2376 new distributors in the current year as part of an expansion drive.

It plans to open open 14 new branches, will take its total network to 117 branches across the country, an official statement said, adding three branches will be revamped.

**********

Indianmoney.com gets insurance broking license Indianmoney.com Thursday said it has received insurance broking license from from insurance regulator Irdai.

The license has been granted to

Indianmoneyinsurance.com, a subsidiary of the Bengaluru-based company, an official statement said.

**********

MEP Infrastructure Q3 FY19 net drops 47.28% MEP Infrastructure Developers Thursday reported 47.28 per cent decline in net profit for the quarter ended December 31, 2018 at Rs 13.10 crore mainly on the back higher taxes and increase in operating and maintenance cost.

The company had reported a net profit of Rs 24.85 crore in the corresponding quarter last fiscal.

Its total revenues stood at Rs 733.34 crore from Rs 771.22 crore, registering a decline of 4.91 per cent in Q3 FY2019.

 

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)